Bladder squamous cell carcinoma biomarkers derived from proteomics.
Proteomics provide powerful technology for analyzing the expression levels of thousands of proteins simultaneously both in health and disease. Here, we review proteomic strategies that we have developed to identify metaplastic lesions in bladder squamous cell carcinomas as well as biomarkers in the urine for follow-up studies of squamous cell carcinoma (SCC)-bearing patients.
Celis
J E
JE
Department of Medical Biochemistry and Danish Center for Human Genome Research, The University of Aarhus, Denmark. jec@biokemi.au.dk
Wolf
H
H
Ostergaard
M
M
D014408:Biomarkers, Tumor / Q000652:urine*; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D020543:Proteome; D001749:Urinary Bladder Neoplasms / Q000378:metabolism* / Q000473:pathology
D014408:Biomarkers, Tumor; D020543:Proteome